Durata Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Durata Therapeutics, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $1.82 per share as of 2013-09-30, per its 10-Q filed 2013-11-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2013-11-06
- 2013-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $1.82.
- 2013-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $1.65.
- 2013-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $1.46.
- 2012-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $1.31.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2013-09-30 | $1.82 10-Q · filed 2013-11-06 |
| 2013-06-30 | $1.65 10-Q · filed 2013-08-07 |
| 2013-03-31 | $1.46 10-Q · filed 2013-05-09 |
| 2012-09-30 | $1.31 10-Q · filed 2012-11-09 |
| 2012-06-30 | $1.31 10-Q · filed 2012-09-04 |